Stay updated on Sparsentan in IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.

Latest updates to the Sparsentan in IgA Nephropathy: Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.6.6, indicating a small system update that replaces the previous v3.6.5. There are no changes to the study details or publicly visible content.SummaryDifference0.0%

- Check12 days agoChange DetectedAdds '2017 ( U.S. NIH Grant/Contract )' to the study's identifiers, indicating NIH funding for the PROTECT trial.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page reflects a newer revision tag (v3.6.5) replacing the prior v3.6.4, indicating an internal update to the page’s documentation or underlying build.SummaryDifference0.0%

- Check40 days agoChange DetectedA new revision tag, Revision: v3.6.4, was added to the page, replacing Revision: v3.6.3 and signaling a small CMS/content update.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.6.3 was added, replacing v3.6.2. This marks an update to the page revision without altering the study information presented.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer build of the page.SummaryDifference0.0%

Stay in the know with updates to Sparsentan in IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sparsentan in IgA Nephropathy: Clinical Trial page.